Cargando…
Challenges of Developing Novel Vaccines With Particular Global Health Importance
Six of the top ten leading causes of death in low resource settings could potentially be prevented by vaccination. Development of vaccines for individuals in these populations is difficult because of the biological complexity of the prevalent pathogens and the challenges inherent to development of a...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7591467/ https://www.ncbi.nlm.nih.gov/pubmed/33162972 http://dx.doi.org/10.3389/fimmu.2020.517290 |
_version_ | 1783601000566751232 |
---|---|
author | Heaton, Penny M. |
author_facet | Heaton, Penny M. |
author_sort | Heaton, Penny M. |
collection | PubMed |
description | Six of the top ten leading causes of death in low resource settings could potentially be prevented by vaccination. Development of vaccines for individuals in these populations is difficult because of the biological complexity of the prevalent pathogens and the challenges inherent to development of any vaccine. This review discusses those challenges and promising advances to address them and highlights recent progress in development of vaccines against several pathogens of interest. |
format | Online Article Text |
id | pubmed-7591467 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-75914672020-11-05 Challenges of Developing Novel Vaccines With Particular Global Health Importance Heaton, Penny M. Front Immunol Immunology Six of the top ten leading causes of death in low resource settings could potentially be prevented by vaccination. Development of vaccines for individuals in these populations is difficult because of the biological complexity of the prevalent pathogens and the challenges inherent to development of any vaccine. This review discusses those challenges and promising advances to address them and highlights recent progress in development of vaccines against several pathogens of interest. Frontiers Media S.A. 2020-10-14 /pmc/articles/PMC7591467/ /pubmed/33162972 http://dx.doi.org/10.3389/fimmu.2020.517290 Text en Copyright © 2020 Heaton. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Heaton, Penny M. Challenges of Developing Novel Vaccines With Particular Global Health Importance |
title | Challenges of Developing Novel Vaccines With Particular Global Health Importance |
title_full | Challenges of Developing Novel Vaccines With Particular Global Health Importance |
title_fullStr | Challenges of Developing Novel Vaccines With Particular Global Health Importance |
title_full_unstemmed | Challenges of Developing Novel Vaccines With Particular Global Health Importance |
title_short | Challenges of Developing Novel Vaccines With Particular Global Health Importance |
title_sort | challenges of developing novel vaccines with particular global health importance |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7591467/ https://www.ncbi.nlm.nih.gov/pubmed/33162972 http://dx.doi.org/10.3389/fimmu.2020.517290 |
work_keys_str_mv | AT heatonpennym challengesofdevelopingnovelvaccineswithparticularglobalhealthimportance |